跳至主要内容
临床试验/NCT05938829
NCT05938829尚未招募不适用

Fetal Growth Restriction: Management Using Two Guidelines (FAME) - Fetal Growth Antenatal Management Evaluation

The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 1,100 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,100
试验地点
2
主要终点
Number of neonates who have composite neonatal adverse outcomes (CNAO)

研究概览

简要总结

The purpose of this study is to compare the composite neonatal adverse outcomes (CNAO) among pregnancies complicated by fetal growth restriction (FGR) managed using the Society of Maternal-Fetal Medicine (SMFM) versus International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) antepartum ultrasound guidelines, to measure the rate of the individual components of CNAO, to record the rate of cesarean delivery during labor, to tabulate the rate of deviation from the management protocol assigned at the time of evaluation, to record neonatal intensive care unit (NICU) admission rates and to measure the rate of the composite maternal adverse outcome (CMAO).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • FGR diagnosed during sonographic examinations
  • estimated fetal weight less than or a fetal abdominal circumference less than the 10th percentile

排除标准

  • Multiple gestations with FGR

结局指标

主要结局

Number of neonates who have composite neonatal adverse outcomes (CNAO)

时间窗: from time of birth to 30 days after birth

次要结局

  • Number of participants that need mechanical ventilation(6 hours after birth)
  • Number of cesarean deliveries(at the time of delivery)
  • Number of participants that are admitted to neonatal intensive care unit (NICU)(from time of birth to 30 days after birth)
  • Number of participants for whom there was a deviation from the management protocol(from time of diagnosis of fetal growth restriction to delivery)
  • Number of mothers who have composite maternal adverse outcomes (CMAO)(from time of birth to 30 days after birth)
  • Number of participants with Apgar score < 7(at 5 minutes after birth)
  • Number of participants that have culture-proven neonatal sepsis(from time of birth to 30 days after birth)
  • Number of participants that are still born or show neonatal death(from time of birth to 30 days after birth)
  • Number of participants that show signs of neonatal seizure(from time of birth to 30 days after birth)
  • Number of participants that have intracranial hemorrhage(from time of birth to 30 days after birth)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hector Mendez-Figueroa

Associate Professor

The University of Texas Health Science Center, Houston

研究点 (2)

Loading locations...

相似试验